Category: Article
Optimizing Global Early-phase Oncology Trials Strategies for Success The clinical trial landscape is constantly evolving, particularly in oncology early development, Read Now 
The Role of Company Culture in Functional Service Provider (FSP) Partnerships Pharmaceutical and clinical research sponsors (clients) have long outsourced clinical development work, utilizing both full-service Read Now 
Traditional Site Networks Are Broken Building Real Site Relationships to Facilitate the Success of Early Phase Oncology Trials Oncology clinical Read Now 
Ensuring Flexibility when Approaching CTIS When Catalyst Oncology implements the European Union Clinical Trial Regulation (EU CTR) across Sponsor studies Read Now 
Catalyst Flex Excels as an Adaptable, Comprehensive FSP The biopharmaceutical industry increasingly turns to Catalyst Flex for its unique approach to functional service Read Now 
Benefits of Working with Catalyst Oncology versus a Large Generalist CRO Oncology drug development continues to increase in its complexity. Large contract research organizations (CROs) are Read Now 
Expanding Clinical Trial Diversity: A Catalyst Values Approach “Today, overall cancer clinical trial enrollment in the United States is 8% (6.3%‐7.0% at community Read Now 
A Reflection on the European Regulatory Framework Historically gaining regulatory approval across multiple countries within the European Union (EU) was segmented, excessively Read Now 
Early Phase Oncology Site Network: Benefits of a Personal Touch Network models for large contract research organizations (CROs) tend to focus on high volume and Read Now 
Catalyst Living the Values Awards 2023 At Catalyst Clinical Research, our people are the foundation of our organization and culture. Team Read Now